BioCatalystWatch
COGTWorkspace / COGT / OverviewCompany library
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc.

Cogent Biosciences, Inc. (COGT)

Website

Price
Market cap
Next catalystNov 30, 2026Bezuclastinib plus sunitinib — GIST indication overview · Regulatory decisionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

CGT4859

Small molecule

FGFR2 × FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Bezuclastinib

Small molecule

mutant KIT, including KIT D816V

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Bezuclastinib

Small molecule

mutant KIT, including KIT D816V

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CGT1145

JAK2 V617F

Upcoming / outlook

CGT1815

KRAS

Upcoming / outlook

CGT4255

HER2 / ErbB2

PreINDP1P2P3FilingApproved
Upcoming / outlook

CGT6297

PI3Kα H1047R

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CGT4859

Small molecule

FGFR2 × FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

CGT6297

PI3Kα H1047R

PreINDP1P2P3FilingApproved
Upcoming / outlook

CGT4255

HER2 / ErbB2

PreINDP1P2P3FilingApproved
Upcoming / outlook

CGT1145

JAK2 V617F

Upcoming / outlook

CGT1815

KRAS

Upcoming / outlook

History / paused

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

COGT PR & News

COGT SEC archive